AG001IZZ

144143-96-4 | 4-({2-butyl-5-[(1E)-2-carboxy-2-(thiophen-2-ylmethyl)eth-1-en-1-yl]-1H-imidazol-1-yl}methyl)benzoic acid; methanesulfonic acid

Chemical structure of 4-({2-butyl-5-[(1E)-2-carboxy-2-(thiophen-2-ylmethyl)eth-1-en-1-yl]-1H-imidazol-1-yl}methyl)benzoic acid; methanesulfonic acid, CAS 144143-96-4
AG001IZZ
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 144143-96-4
Catalog Number AG001IZZ(AGN-PC-0PV2UD)
Chemical Name 4-({2-butyl-5-[(1E)-2-carboxy-2-(thiophen-2-ylmethyl)eth-1-en-1-yl]-1H-imidazol-1-yl}methyl)benzoic acid; methanesulfonic acid
IUPAC Name 4-[[2-butyl-5-[(E)-2-carboxy-3-thiophen-2-ylprop-1-enyl]imidazol-1-yl]methyl]benzoic acid;methanesulfonic acid
InChI InChI=1S/C23H24N2O4S.CH4O3S/c1-2-3-6-21-24-14-19(12-18(23(28)29)13-20-5-4-11-30-20)25(21)15-16-7-9-17(10-8-16)22(26)27;1-5(2,3)4/h4-5,7-12,14H,2-3,6,13,15H2,1H3,(H,26,27)(H,28,29);1H3,(H,2,3,4)/b18-12+;
InChI Key DJSLTDBPKHORNY-XMMWENQYSA-N
MDL Number MFCD08141807
Molecular Formula C24H28N2O7S2
Molecular Weight 520.6183
SMILES O=C(O)C1=CC=C(CN2C(/C=C(C(O)=O)\CC3=CC=CS3)=CN=C2CCCC)C=C1.CS(=O)(O)=O
UNII 8N2L1NX8S3
Synonyms
eprosartan, SK and F 108566, SKF-108566, Teveten, EPROSARTAN MESYLATE, 144143-96-4, Teveten, eprosartan methanesulfonate, Eprosartan (mesylate), Eprosartan mesilate, UNII-8N2L1NX8S3, Eprosartan mesylate [USAN:BAN], SK&F 108566-J, 8N2L1NX8S3, CHEBI:48409, SKF-108566J, (E)-2-Butyl-1-(p-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acid, monomethanesulfonate, SK&F-108566-J, DSSTox_CID_24217, DSSTox_RID_80124, DSSTox_GSID_44217, Eprosartan mesylate dihydrate, 2-Thiophenepropanoic acid, alpha-((2-butyl-1-((4-carboxyphenyl)methyl)-1H-imidazol-5-yl)methylene)-, (E)-, monomethanesulfonate, CAS-144143-96-4, NCGC00164557-01, Eprosartan Monomethanesulfonate, Futuran, Navixen, Regulaten, Tevetenz, Epro-sartan mesylate dihydrate, SR-05000001450, MFCD08141807, Teveten SB, C23H24N2O4S.CH4O3S, eprosartan-mesylate, Teveten (TN), AC1NR04M, Eprosartan mesylate (USAN), SCHEMBL41396, sunitinib and its intermediate, CHEMBL1200987, DTXSID7044217, AOB5517, DJSLTDBPKHORNY-XMMWENQYSA-N, HMS3262B17, 4-[[2-Butyl-5-(2-carboxy-3-thiophen-2-yl-prop-1-enyl)-imidazol-1-yl]methyl]benzoic acid mesylate, Tox21_112186, Tox21_500808, HY-15834A, s4102, SK&F-108566J, AKOS015994738, Eprosartan mesylate, >=98% (HPLC), Tox21_112186_1, AM84399, CCG-222112, CS-2291, KS-1233, MP-0196, SKF 108566, NCGC00167505-02, NCGC00261493-01, AB0069224, LS-173203, ST2412854, E-145, E1161, SW219286-1, A13747, D02082, 92605-EP2295430A2, 92605-EP2295431A2, 92605-EP2305670A1, 143E964, A808180, J-007923, SR-05000001450-2, Eprosartan mesylate, United States Pharmacopeia (USP) Reference Standard, (|AE)-|A-[[2-Butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazol-5-yl]methylene]-2-thiophenepropanoic Acid Monomethanesulfonate, (E)-|A-[[2-Butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazol-5-yl]methylene]-2-thiophenepropanoic Acid Methanesulfonate, (E)-2-butyl-1-(p-carboxybenzyl)-alpha-2-thienylimidazole-5-acrylic acid monomethanesulfonate, (E)-4-((2-butyl-5-(2-carboxy-3-(thiophen-2-yl)prop-1-en-1-yl)-1H-imidazol-1-yl)methyl)benzoic acid compound with methanesulfonic acid (1:1), (E)-alpha-((2-butyl-1-((4-carboxyphenyl)methyl)-1H-imidazol-5-yl)methylene)-2-thiophenepropanoic acid monomethanesulfonate, 2-Thiophenepropanoic acid, alpha-[[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazol-5-yl]methylene]-, (alphaE)-, methanesulfonate (1:1), 4-({2-butyl-5-[(1E)-2-carboxy-3-(2-thienyl)prop-1-en-1-yl]-1H-imidazol-1-yl}methyl)benzoic acid methanesulfonate, 4-[[2-butyl-5-[(E)-2-carboxy-3-thiophen-2-ylprop-1-enyl]-1-imidazolyl]methyl]benzoic acid; methanesulfonic acid, 4-[[2-butyl-5-[(E)-2-carboxy-3-thiophen-2-ylprop-1-enyl]imidazol-1-yl]methyl]benzoic acid;methanesulfonic acid, 4-[[2-butyl-5-[(E)-2-carboxy-3-thiophen-2-ylprop-1-enyl]imidazol-1-yl]methyl]benzoic acid;methanesulfonic acid., 4-[[2-butyl-5-[(E)-3-hydroxy-3-oxo-2-(thiophen-2-ylmethyl)prop-1-enyl]imidazol-1-yl]methyl]benzoic acid; methanesulfonic acid, 4-[[2-butyl-5-[(E)-3-oxidanyl-3-oxidanylidene-2-(thiophen-2-ylmethyl)prop-1-enyl]imidazol-1-yl]methyl]benzoic acid; methanesulfonic acid, Eprosartan mesylate|SK&F 108566|(?E)-?-[[2-Butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazol-5-yl]methylene]-2-thiophenepropanoic acid methanesulfonate, Eprosartan, TEVETEN HCT, cc-130, CID5282474, CS-O-01462, SK&F-108566, B1746, C23-H24-N2-O4-S.C-H4-O3-S, 133040-01-4,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited